The People

Experimental Oral GLP-1 Pill Drives Nearly 12% Weight Loss in Trial

via The Hill·Jun 28

An experimental oral GLP-1 drug produced nearly 12% weight loss over 36 weeks in a new study, offering a potential pill-based alternative to injectable treatments. Researchers found the medication stimulates insulin secretion, suppresses appetite and boosts feelings of fullness.

Read Full Story at The Hill
healthscience

Related Stories

Experimental Drug Repairs DNA Damage in Earliest Stages of Alzheimer's

Good News Network·7h ago

North Dakota Men Who Discovered They Were Switched at Birth Sue Hospital

The Guardian·7h ago

Safety Fears Hamper Ebola Response in Congo Amid Attacks on Health Workers

Washington Times·7h ago

Arizona Teen Praised for Rescuing Woman With Dementia in 103-Degree Heat

The Guardian·13h ago
DiscussSoon
← Front Page